Neuroserpin

Standard

Neuroserpin. / Galliciotti, Giovanna; Sonderegger, Peter.

in: FRONT BIOSCI-LANDMRK, Jahrgang 11, 2006, S. 33-45.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Galliciotti, G & Sonderegger, P 2006, 'Neuroserpin', FRONT BIOSCI-LANDMRK, Jg. 11, S. 33-45.

APA

Galliciotti, G., & Sonderegger, P. (2006). Neuroserpin. FRONT BIOSCI-LANDMRK, 11, 33-45.

Vancouver

Galliciotti G, Sonderegger P. Neuroserpin. FRONT BIOSCI-LANDMRK. 2006;11:33-45.

Bibtex

@article{ad94f572639a447e8464eb6c5932f288,
title = "Neuroserpin",
abstract = "Neuroserpin is a member of the serpin family of serine protease inhibitors. Tissue distribution analysis reveals a predominantly neuronal expression during the late stages of neurogenesis and, in the adult brain, in areas where synaptic changes are associated with learning and memory (synaptic plasticity). In vitro studies revealed complex formation between neuroserpin and different serine proteases, i.e. tPA, uPA, and plasmin. The neuroserpin-target complex has so far not been characterized in vivo. However, some investigations help to understand the functional role of this serpin. Neuroserpin was shown to be involved in the regulation of the morphology of neuroendocrine cells in culture, possibly by modulating the degradation of the extracellular matrix by proteolytic enzymes such as tPA. Moreover, a role of neuroserpin in mood regulation has been deduced from the over- and underexpression of neuroserpin in genetically modified mice, which showed increased anxiety and novelty-induced hypo-locomotion. In pathological conditions of the central nervous system (i.e. stroke and seizures), neuroserpin plays a neuroprotective role, probably by blocking the deleterious effects of tPA. A familial form of a neurodegenerative disease, termed familial encephalopathy with neuroserpin inclusion bodies, is caused by point mutations in the neuroserpin gene. This condition is characterized by the intracellular polymerization and accumulation of mutated neuroserpin, leading to neuronal death and dementia.",
keywords = "Animals, Brain Diseases, Emotions, Gene Expression Regulation, Gene Expression Regulation, Developmental, Genetic Variation, Humans, Inclusion Bodies, Neoplasms, Neurodegenerative Diseases, Neurons, Neuropeptides, Neurosecretory Systems, Oligonucleotide Array Sequence Analysis, RNA, Messenger, Seizures, Serine Proteinase Inhibitors, Serpins, Stroke",
author = "Giovanna Galliciotti and Peter Sonderegger",
year = "2006",
language = "English",
volume = "11",
pages = "33--45",
journal = "FRONT BIOSCI-LANDMRK",
issn = "2768-6701",
publisher = "Frontiers in Bioscience",

}

RIS

TY - JOUR

T1 - Neuroserpin

AU - Galliciotti, Giovanna

AU - Sonderegger, Peter

PY - 2006

Y1 - 2006

N2 - Neuroserpin is a member of the serpin family of serine protease inhibitors. Tissue distribution analysis reveals a predominantly neuronal expression during the late stages of neurogenesis and, in the adult brain, in areas where synaptic changes are associated with learning and memory (synaptic plasticity). In vitro studies revealed complex formation between neuroserpin and different serine proteases, i.e. tPA, uPA, and plasmin. The neuroserpin-target complex has so far not been characterized in vivo. However, some investigations help to understand the functional role of this serpin. Neuroserpin was shown to be involved in the regulation of the morphology of neuroendocrine cells in culture, possibly by modulating the degradation of the extracellular matrix by proteolytic enzymes such as tPA. Moreover, a role of neuroserpin in mood regulation has been deduced from the over- and underexpression of neuroserpin in genetically modified mice, which showed increased anxiety and novelty-induced hypo-locomotion. In pathological conditions of the central nervous system (i.e. stroke and seizures), neuroserpin plays a neuroprotective role, probably by blocking the deleterious effects of tPA. A familial form of a neurodegenerative disease, termed familial encephalopathy with neuroserpin inclusion bodies, is caused by point mutations in the neuroserpin gene. This condition is characterized by the intracellular polymerization and accumulation of mutated neuroserpin, leading to neuronal death and dementia.

AB - Neuroserpin is a member of the serpin family of serine protease inhibitors. Tissue distribution analysis reveals a predominantly neuronal expression during the late stages of neurogenesis and, in the adult brain, in areas where synaptic changes are associated with learning and memory (synaptic plasticity). In vitro studies revealed complex formation between neuroserpin and different serine proteases, i.e. tPA, uPA, and plasmin. The neuroserpin-target complex has so far not been characterized in vivo. However, some investigations help to understand the functional role of this serpin. Neuroserpin was shown to be involved in the regulation of the morphology of neuroendocrine cells in culture, possibly by modulating the degradation of the extracellular matrix by proteolytic enzymes such as tPA. Moreover, a role of neuroserpin in mood regulation has been deduced from the over- and underexpression of neuroserpin in genetically modified mice, which showed increased anxiety and novelty-induced hypo-locomotion. In pathological conditions of the central nervous system (i.e. stroke and seizures), neuroserpin plays a neuroprotective role, probably by blocking the deleterious effects of tPA. A familial form of a neurodegenerative disease, termed familial encephalopathy with neuroserpin inclusion bodies, is caused by point mutations in the neuroserpin gene. This condition is characterized by the intracellular polymerization and accumulation of mutated neuroserpin, leading to neuronal death and dementia.

KW - Animals

KW - Brain Diseases

KW - Emotions

KW - Gene Expression Regulation

KW - Gene Expression Regulation, Developmental

KW - Genetic Variation

KW - Humans

KW - Inclusion Bodies

KW - Neoplasms

KW - Neurodegenerative Diseases

KW - Neurons

KW - Neuropeptides

KW - Neurosecretory Systems

KW - Oligonucleotide Array Sequence Analysis

KW - RNA, Messenger

KW - Seizures

KW - Serine Proteinase Inhibitors

KW - Serpins

KW - Stroke

M3 - SCORING: Journal article

C2 - 16146712

VL - 11

SP - 33

EP - 45

JO - FRONT BIOSCI-LANDMRK

JF - FRONT BIOSCI-LANDMRK

SN - 2768-6701

ER -